Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Heuking

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|December 23, 2011
Toll-like receptor-7 agonist decoration enhances the adjuvanticity of chitosan-DNA nanoparticlesSimon Heuking, Gerrit Borchard
Molecular Pharmaceutics|July 23, 2013
Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunizationCharlotte Primard, Johanna Poecheim, Simon Heuking, et al.
Journal of Nanobiotechnology|August 23, 2013
Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitroSimon Heuking, Barbara Rothen-Rutishauser, David Olivier Raemy, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine ReleaseJohanna Poecheim, Simon Heuking, Livia Brunner, et al.
Journal of Drug Targeting|August 22, 2009
Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriersSimon Heuking, Sarah Adam-Malpel, Emmanuelle Sublet, et al.
BMC Immunology|February 2, 2018
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluationSumera Y Younis, Christophe Barnier-Quer, Simon Heuking, et al.
The Journal of Infectious Diseases|November 26, 2013
Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureusKaren Misstear, Edel A McNeela, Alison G Murphy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|December 23, 2011
Toll-like receptor-7 agonist decoration enhances the adjuvanticity of chitosan-DNA nanoparticlesSimon Heuking, Gerrit Borchard
Molecular Pharmaceutics|July 23, 2013
Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunizationCharlotte Primard, Johanna Poecheim, Simon Heuking, et al.
Journal of Nanobiotechnology|August 23, 2013
Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitroSimon Heuking, Barbara Rothen-Rutishauser, David Olivier Raemy, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine ReleaseJohanna Poecheim, Simon Heuking, Livia Brunner, et al.
Journal of Drug Targeting|August 22, 2009
Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriersSimon Heuking, Sarah Adam-Malpel, Emmanuelle Sublet, et al.
BMC Immunology|February 2, 2018
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluationSumera Y Younis, Christophe Barnier-Quer, Simon Heuking, et al.
The Journal of Infectious Diseases|November 26, 2013
Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureusKaren Misstear, Edel A McNeela, Alison G Murphy, et al.
Pageof 1